DPIIT recognised startup Government of India
Startup India
Ur Advanced Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹56.92 Lakh
▲ 80% YoY
Net loss · FY 2025
₹33.99 Lakh
Net margin -59.7%
EBITDA · FY 2025
₹15.59 Lakh
EBITDA margin 27.4%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹1.3 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Ur Advanced Therapeutics Private Limited
Data last updated:
Ur Advanced Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2020PTC141847. Its GSTIN is 36AACCU6281G1Z6 (Telangana).
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹1.3 Cr. It is led by directors including Sai Pooja Anne and Aparna Rachamallu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villa No.19 Sark – 2 Mokila, Hyderabad, Telangana, India – 501203.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.92 Lakh, a growth of 80% compared to the previous year. For the same year it recorded a net loss of ₹33.99 Lakh (net margin -59.7%) and EBITDA of ₹15.59 Lakh (EBITDA margin 27.4%). Revenue has grown at a compounded annual rate (CAGR) of 167% over three years.
The company is associated with 1 brand: UR Advanced Therapeutics.
Ur Advanced Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0030280). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uratpx.com.
Company details
CIN U73100TG2020PTC141847
Registration Number 141847
Incorporation Date 17 July 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0030280
Key People
Sai Pooja Anne Director Aparna Rachamallu Director Jangamreddy Jagan Mohan Reddy Director Recognitions & Rankings of Ur Advanced Therapeutics
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0030280
Contact details
Ur Advanced Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is uratpx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVilla No.19 Sark – 2 Mokila, Hyderabad, Telangana, India – 501203
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Ur Advanced Therapeutics Private Limited, buy the company report.
Comprehensive company report
Ur Advanced Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ur Advanced Therapeutics operates one associated brand: UR Advanced Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Designs peptides for tissue engineering, drug discovery, and lab services. | uratpx.com |
Business activity
The main business activity of Ur Advanced Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Ur Advanced Therapeutics Private Limited, buy the company report.
Financials of Ur Advanced Therapeutics Private Limited
FY 2025 filings availableUr Advanced Therapeutics Private Limited reported revenue of ₹56.92 Lakh (up 80% YoY) for FY 2025.
Revenue · FY 2025
₹56.92 Lakh ▲ 80%
Net loss · FY 2025
₹33.99 Lakh margin -59.7%
EBITDA · FY 2025
₹15.59 Lakh margin 27.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 167%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 59%
Revenue has grown at a compounded annual rate (CAGR) of 167% over three years, including 80% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹33.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.4% | ||||
| Net Profit Margin | -59.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ur Advanced Therapeutics Private Limited, buy the company report.
Board of directors of Ur Advanced Therapeutics Private Limited
Ur Advanced Therapeutics has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sai Pooja Anne | Director | 16 Dec 2023 | 2 Years 10 Months | Current |
| Aparna Rachamallu | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Jangamreddy Jagan Mohan Reddy Also directs: Ur Revnostics Private Limited | Director | 17 Jul 2020 | 6 Years 3 Months | Current |
| Bhanu Prasad Kommineni Also directs: Bhan Pharmainfo Private Limited, Apogen Remedies Private Limited | Director | 16 Dec 2023 | 2 Years 10 Months | Current |
Auditor
Ur Advanced Therapeutics Private Limited is audited by M N Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N Reddy & Co | FY 2023 | 010025S |
Shareholding
The shareholding of Ur Advanced Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ur Advanced Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ur Advanced Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ur Advanced Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ur Advanced Therapeutics Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Ur Advanced Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCU6281G1Z6 | Telangana | Active | 24 Nov 2020 |
To see the full GST registrations and return filing status of Ur Advanced Therapeutics Private Limited, buy the company report.
Recent activity
Ur Advanced Therapeutics Private Limited has 8 board changes on record since 2020: 4 appointments and 4 cessations. The latest: Bhanu Prasad Kommineni ceased to be Additional Director on 29 Sep 2024.
AGM
Ur Advanced Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ur Advanced Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Bhanu Prasad Kommineni ceased to be Additional Director.
Ceased
Sai Pooja Anne ceased to be Additional Director.
Appointed
Bhanu Prasad Kommineni was appointed as Director.
Appointed
Sai Pooja Anne was appointed as Director.
Appointed
Aparna Rachamallu was appointed as Director.
Ceased
Kummetha Raghunathareddy ceased to be Additional Director.
Ceased
Adinarayana Reddy Yerrapureddy ceased to be Director.
Appointed
Jangamreddy Jagan Mohan Reddy was appointed as Director.
Incorporation
17 Jul 2020
Ur Advanced Therapeutics Private Limited was registered on 17 Jul 2020 with Roc Hyderabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Ur Advanced Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 July 2020 (6+ years old) and is registered under CIN U73100TG2020PTC141847.
Ur Advanced Therapeutics has 4 current directors:
- Sai Pooja Anne - Director
- Aparna Rachamallu - Director
- Jangamreddy Jagan Mohan Reddy - Director
- Bhanu Prasad Kommineni - Director
The latest financial statements of Ur Advanced Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ur Advanced Therapeutics is 36AACCU6281G1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Ur Advanced Therapeutics is U73100TG2020PTC141847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ur Advanced Therapeutics was incorporated on 17 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bhanu Prasad Kommineni ceased to be Additional Director on 29 Sep 2024. Sai Pooja Anne ceased to be Additional Director on 29 Sep 2024. Bhanu Prasad Kommineni was appointed as Director on 16 Dec 2023. Ur Advanced Therapeutics has 8 board changes on record in total.
Yes, Ur Advanced Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Ur Advanced Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0030280).
Ur Advanced Therapeutics can be reached through the website uratpx.com. Its registered office is in Hyderabad, Telangana, India.